Home › Stocks › GENB

GENB — GENERATE BIOMEDICINES INC

Reported value held$1.89B
Funds holding (latest)131
SectorHealth Care

What is a 13F filing? Who files one and when · What 13F filings can't tell you

Funds holding (Q2 2026)92
Institutional value$1.79B · 108.21M sh
New / Add / Cut / Exit44 / 26 / 11 / 15 · Updated 2026-11-14
Top-5 / Top-10 concentration75.1% / 84.1%
Institutional holdings change Accumulating +1.7% (+1.73M sh)
Institutional value change Up +37.6%

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

As of Q2 2026, 92 SEC-registered investment managers reported holding GENB (GENERATE BIOMEDICINES INC) in their latest 13F filings, with a combined reported value of $1.79B across 108.21M shares. That is +1.7% by share count (+1.73M shares) versus the previous quarter, while reported value moved +37.6%. Ownership is concentrated: the five largest holders account for 75.1% of reported value and the top ten for 84.1%.

Compared with the prior quarter, 44 opened new positions, 26 added to existing stakes, 11 trimmed, 15 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.

Major shareholders of GENERATE BIOMEDICINES INC (GENB) include Flagship Pioneering, LLC, Fidelity Management & Research (FMR), Capital World Investors, ranked by reported 13F value among the 131 institutional holders on this page.

GENB is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

Legendary Investors Holding GENB

The superinvestors we track who report GENB in their latest 13F filing — each shown at that manager’s own most recent quarter.

Investor Quarter Shares Value Portfolio Weight Change
ARK Invest Q3 2026 1.96M $29.51M 0.17% Add

Which stocks do these investors own together? →  ·  Embed this widget →

Institutional Ownership by Quarter

Quarter Funds holding Shares Value QoQ Net Change
Q3 2026 69 27.72M $417.54M +26.6%
Q2 2026 92 108.21M $1.79B +1.7%
Q1 2026 63 100.53M $1.23B —

Over the 3 quarters shown, institutional share counts decreased 72% in aggregate (Q1 2026 → Q3 2026).

Top Institutional Holders (Q3 2026) — 25 funds

FundSharesValuePortfolio WeightChange
Fidelity Management & Research (FMR) 7.19M $107.94M 0.01% Add
Capital World Investors 4.20M $63.11M 0.01% Hold
JPMorgan Chase & Co 2.65M $40.94M 0.01% Add
VANGUARD CAPITAL MANAGEMENT LLC 2.24M $33.58M 0.00% Add
ARK Invest 1.96M $29.51M 0.17% Add
BlackRock Inc 1.83M $27.49M 0.00% Add
BANQUE PICTET & CIE SA history 1.77M $26.63M 0.39% New
Davern Capital Partners, LP history 824.68K $12.39M 2.41% Hold
Siren, L.L.C. 736.10K $11.06M 0.26% Hold
Geode Capital Management 729.08K $10.95M 0.00% Reduce
STATE STREET CORP 546.34K $8.21M 0.00% New
Morgan Stanley 522.41K $7.85M 0.00% Add
VANGUARD FIDUCIARY TRUST CO 204.18K $3.07M 0.00% Add
TD ASSET MANAGEMENT INC 180.00K $2.78M 0.00% Add
ALPS ADVISORS INC 170.04K $2.55M 0.01% Add
VANGUARD PORTFOLIO MANAGEMENT LLC 169.76K $2.55M 0.00% Add
Prosight Management, LP history 144.76K $2.17M 0.42% New
Savant Capital, LLC 139.42K $2.09M 0.01% New
UBS Group AG 126.95K $1.91M 0.00% Reduce
Quadrature Capital Ltd 120.30K $1.81M 0.01% Add
BARCLAYS PLC 118.47K $1.78M 0.00% Add
Manulife Financial 115.99K $1.74M 0.00% Add
Affinity Asset Advisors, LLC 100.00K $1.50M 0.07% Reduce
Nuveen, LLC 85.28K $1.28M 0.00% Add
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84.96K $1.28M 0.08% Add

↑ Back to the top of the holders list

Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders

Q2 2026 — 25 funds

FundSharesValuePortfolio WeightChange
Flagship Pioneering, LLC history 62.67M $1.06B 68.66% Hold
Fidelity Management & Research (FMR) 5.22M $88.09M 0.00% Add
Capital World Investors 4.22M $71.12M 0.01% Add
Capital World Investors 4.22M $71.12M 0.01% Add
BRAIDWELL LP history 3.28M $55.40M 2.18% Reduce
PRICE T ROWE ASSOCIATES INC /MD/ 2.16M $36.38M 0.00% Add
Norges Bank Investment Management 2.09M $35.34M 0.00% New
ARCH Venture Management, LLC history 1.94M $32.80M 2.98% Hold
HARBOURVEST PARTNERS LLC history 1.72M $29.05M 17.09% Hold
BlackRock Inc 1.66M $28.00M 0.00% New
BAKER BROS. ADVISORS LP 1.42M $24.02M 0.13% Hold
JPMorgan Chase & Co 1.41M $23.84M 0.00% Reduce
Deep Track Capital, LP 1.33M $22.50M 0.34% New
ARK Invest 1.28M $21.67M 0.14% Add
VANGUARD CAPITAL MANAGEMENT LLC 1.13M $19.11M 0.00% Add
Harvard Management Company history 1.11M $18.74M 0.91% Hold
HARVARD MANAGEMENT CO INC 1.11M $18.74M 0.44% Hold
NVIDIA CORP history 833.33K $14.06M 0.02% Hold
Davern Capital Partners, LP history 824.68K $13.91M 2.37% Add
Siren, L.L.C. 736.10K $12.42M 0.25% Hold
GEODE CAPITAL MANAGEMENT, LLC 735.00K $12.40M 0.00% New
Geode Capital Management 735.00K $12.40M 0.00% Add
Affinity Asset Advisors, LLC 400.00K $6.75M 0.33% Add
Morgan Stanley 377.99K $6.38M 0.00% Add
UBS Group AG 326.27K $5.50M 0.00% Reduce

Q1 2026 — 25 funds

FundSharesValuePortfolio WeightChange
Flagship Pioneering, LLC history 62.67M $783.41M 67.44% New
Fidelity Management & Research (FMR) 4.22M $52.72M 0.00% New
Capital World Investors 4.00M $50.05M 0.01% New
Capital World Investors 4.00M $50.05M 0.01% New
BRAIDWELL LP history 3.59M $44.91M 1.70% New
JPMorgan Chase & Co 2.95M $33.92M 0.00% New
PRICE T ROWE ASSOCIATES INC /MD/ 2.11M $26.37M 0.00% New
ARCH Venture Management, LLC history 1.94M $24.31M 3.59% New
HARBOURVEST PARTNERS LLC history 1.72M $21.53M 21.33% New
BAKER BROS. ADVISORS LP 1.42M $17.80M 0.11% New
Harvard Management Company history 1.11M $13.89M 0.77% New
HARVARD MANAGEMENT CO INC 1.11M $13.89M 0.77% New
NVIDIA CORP history 833.33K $10.42M 0.06% New
Siren, L.L.C. 736.10K $9.20M 0.26% New
Davern Capital Partners, LP history 591.80K $7.40M 2.03% New
Alyeska Investment Group, L.P. 500.00K $6.25M 0.02% New
ARK Invest 498.41K $6.23M 0.05% New
Millennium Management 376.89K $4.71M 0.00% New
MILLENNIUM MANAGEMENT LLC 376.89K $4.71M 0.01% New
UBS Group AG 356.70K $4.46M 0.00% New
Affinity Asset Advisors, LLC 350.00K $4.38M 0.23% New
Morgan Stanley 337.30K $4.22M 0.00% New
ExodusPoint Capital Management, LP 311.99K $3.90M 0.04% New
CenterBook Partners LP 266.81K $3.34M 0.18% New
SPHERA FUNDS MANAGEMENT LTD. 185.00K $2.31M 0.38% New

View all 131 fund holders →

New Positions (Q2 2026)

Fully Exited (vs previous quarter)

Fund Position History — shares by quarter (top 20 funds)

FundQ3 2026Q2 2026Q1 2026
Fidelity Management & Research (FMR) 7.19M 5.22M 4.22M
Capital World Investors 4.20M 4.22M 4.00M
JPMorgan Chase & Co 2.65M 1.41M 2.95M
VANGUARD CAPITAL MANAGEMENT LLC 2.24M 1.13M 131.32K
ARK Invest 1.96M 1.28M 498.41K
BlackRock Inc 1.83M 1.66M —
BANQUE PICTET & CIE SA 1.77M — —
Davern Capital Partners, LP 824.68K 824.68K 591.80K
Siren, L.L.C. 736.10K 736.10K 736.10K
Geode Capital Management 729.08K 735.00K 118.24K
STATE STREET CORP 546.34K — —
Morgan Stanley 522.41K 377.99K 337.30K
VANGUARD FIDUCIARY TRUST CO 204.18K 175.36K 17.46K
TD ASSET MANAGEMENT INC 180.00K 50.75K 42.87K
ALPS ADVISORS INC 170.04K 129.41K —
VANGUARD PORTFOLIO MANAGEMENT LLC 169.76K 167.28K —
Prosight Management, LP 144.76K — —
Savant Capital, LLC 139.42K — —
UBS Group AG 126.95K 326.27K 356.70K
Quadrature Capital Ltd 120.30K 31.51K —

Download holders (CSV)

FAQ

Which funds hold GENB?

As of 2026-Q2, 92 institutional funds reported holding GENB (GENERATE BIOMEDICINES INC) in SEC 13F filings, with a combined reported value of $1.79B.

How many shares of GENB do institutions own?

13F filers reported 108.21M shares of GENB, worth $1.79B in aggregate at the end of 2026-Q2.

Is institutional ownership of GENB rising or falling?

Share counts moved +1.7% versus the prior quarter — accumulation.

Who are the top institutional holders of GENB?

The largest 13F holders are Flagship Pioneering, LLC, Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, BRAIDWELL LP; the top 25 are ranked at the top of this page.

Who are the major shareholders of GENERATE BIOMEDICINES INC?

The major shareholders of GENERATE BIOMEDICINES INC (GENB) by reported 13F value are Flagship Pioneering, LLC, Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, BRAIDWELL LP, among 131 institutional holders.

Which legendary investors own GENB?

1 of the legendary investors tracked on HoldingsHub report GENB (GENERATE BIOMEDICINES INC) in their latest 13F filings, led by ARK Invest. Each is shown at that manager's own most recent quarter.

Do superinvestors agree on GENB?

1 tracked superinvestors hold GENB simultaneously — see the consensus page for the stocks they own together.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.

Embed this stock on your site

Copy the snippet below to show a live "which legendary investors own GENB" list on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/stocks/GENB/widget" width="100%" height="640" frameborder="0" loading="lazy" title="HoldingsHub stock holders"></iframe>

Preview the embeddable widget →